MedTrace Logo

A PHASE I, SINGLE-CENTER, MIXED METHODS STUDY ON THE HEALTH OUTCOMES OF VISUAL SELF EXPRESSION

NCT03155672 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2020-04-15

No results posted yet for this study

Summary

To gain understanding about the impact of visual art making on biomarkers, such as cortisol, alpha amylase, oxytocin, etc. to examine whether and to what extent there are changes in levels of stress and immune function in patients and caregivers adults (including family caregivers and medical professionals)

Conditions

  • A Healthcare Professional, a Patient or Caregiver in the Radiation Oncology Department at the University of Pennsylvania

Interventions

BEHAVIORAL

Art therapy

Art Therapy

Sponsors & Collaborators

  • Abramson Cancer Center at Penn Medicine

    lead OTHER

Principal Investigators

  • William Levin, MD · Abramson Cancer Center at Penn Medicine

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-15
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03155672 on ClinicalTrials.gov